Anti-diabetic activity of different oils through their effect on arylsulfatases by unknown
Samarji and Balbaa Journal of Diabetes & Metabolic Disorders 2014, 13:116
http://www.jdmdonline.com/content/13/1/116RESEARCH ARTICLE Open AccessAnti-diabetic activity of different oils through
their effect on arylsulfatases
Rima Samarji1 and Mahmoud Balbaa2*Abstract
Background: Diabetes mellitus (DM) is characterized by the overproduction of the reactive oxygen species which
affects the integrity of the lysosomal membrane affecting lysosomal enzymes. The effect of these species is blocked
by some natural products as antioxidants. In the current study, groups of normal and streptozotocin (STZ)-induced
diabetic rats were treated by Nigella sativa (NS), olive and canola oils and subjected to the study of arylsulfatases as
a model of lysosomal enzymes. The aim of the present study is to investigate the effect of STZ-induced diabetes on
arylsulfatases in presence and absence of NS, olive and canola oils.
Methods: Different groups of rats were induced by STZ, treated with different oils and compared to their
corresponding control group. All groups were subjected for the assays of blood glucose, insulin, catalase and
arylsulfatases. A comparative kinetic study of arylsulfatses was performed to detect the alteration of catalytic
characterization.
Results: The results demonstrated that diabetes causes a significant elevation in the level of hepatic arylsulfatase B
and a significant reduction of hepatic catalase as an antioxidant enzyme. NS and olive oils returned catalase and
arylsulfatase B activities back near to normal by fixing their catalytic properties. Furthermore, the maximum velocity
of arylsulfatases A and B was significantly elevated in the induced diabetes, whereas their Km values were
significantly changed. The treatment of diabetic rats by NS and olive oils reduced the degree of significance.
Conclusion: Diabetes induces significant alterations of the catalytic characters of arylsulfatases and some oils
decrease this alteration through an antioxidant-mediated effect.
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DM is a chronic metabolic disorder that presents a
major worldwide health problem. DM is characterized
by complete or partial deficiencies in insulin production
and/or insulin action coupled with chronic hyperglycemia
and disruption in metabolism [1]. In DM, oxidative stress
represents an imbalance between the production of free
radicals and the ability of the antioxidant defense mecha-
nisms to detoxify them [2,3]. On the other hand, STZ is
an antibiotic produced by Streptomycetes achromogenes
and is used to stimulate insulin-dependent DM [4].
ASA (EC 3.1.6.8) and ASB (EC 3.1.6.9) are lysosomal en-
zymes, which are involved in the metabolism of glycocon-
jugates. ASA is known as cerebroside-3-sulfohydrolase* Correspondence: mahmoud.balbaa@alexu.edu.eg
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unless otherwise stated.and it desulfates the galactose-3-sulfate residues in cerebro-
side sulfate and other sulfated galactolipids [5]. An increase
in the enzyme concentration was found in the body fluids
of patients with cancer of various organs [6]. ASB desulfates
the non-reducing terminal N-acetylgalactosamine-4-sulfate
residues that are present in glycosaminoglycan [7]. ASB ac-
tivity is increased in different tumors tumors [5,8-11]. DM
is characterized by the overproduction of ROS which affects
the lysosomal membrane integrity [12]. ROS were found to
decline on increasing the antioxidant enzymes [13] and
antioxidant activity of some natural products [14]. It was
found that antioxidant therapy can be subdivided into vita-
mins and supplements, plants and their active ingredients
and drugs with antioxidant potential [14-18]. Also, it was
found a diverse effect of different oils such as Nigela sativa
[19,20] and olive [21-25] oils in DM. It was reported that
both NS and olive oils have antidiabetic and antioxidantentral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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is conducted to investigate the effect of STZ-induced dia-
betes on arylsulfatases in presence and absence of NS, olive
and canola oils. The enzymatic activity of arylsulfatases is
assayed in both liver and serum in all groups and the cata-
lytic parameters of ASA and ASB were determined to de-




Sixty four male albino Sprague–Dawley rats of 4–6
weeks old with an approximate body mass of 200 g were
obtained from the animal house of the Faculty of Sci-
ence, Beirut Arab University. Animals were housed in a
poly carbonate cages (8 animals/cage) under standard-
ized laboratory conditions with a twelve hour day –night
cycle, temperature of 25°C, and humidity of 45% to 60%.
Animals had access to tap water and to standard food
diet ad libitum. The animal protocols were approved by
the regional ethical committee (BAU Ethics Committee).
Chemicals and oils
STZ, DE-52, insulin ELISA kit and p-NCS salt were
purchased from Sigma-Aldrich (Beirut office Lebanon).
p-NCS was prepared as a substrate reagent for ASA
ASB as previously explained [28]. CAT assay kit was
purchased from Biodiagnostic, Diagnostic and Research
Reagents, Giza, Egypt.
Rats treatment
Eight groups of male rats were prepared, each includes 8
rats. Four of these groups were treated with STZ to in-
duce diabetes in them at a dosage of 50 mg/kg as previ-
ously described [4]. Some groups were treated by NS or
olive or canola oils. The different groups were classified
as non-diabetic rats (control), STZ-induced diabetic rats
(GI), control treated with NS oil (GII), diabetic treated
with NS oil (GIII), control treated with Olive oil (GIV),
diabetic treated with Olive oil (GV), control treated with
canola oil (GVI) and diabetic treated with canola oil
(GVII). A dose of 0.2 ml/kg/day of NS, olive and canola
oils were given daily by i.p injection for 4 weeks.
Blood Glucose assay
The blood glucose level was measured 3 days and
4 weeks of STZ-PI and oil treatment, respectively. Glu-
cose levels in all groups were measured by means of a
glucometer by using accu-check strip and the detected
color reflects the glucose concentration in mg/dl [29].
Insulin assay
Insulin is assayed in the pancreatic homogenate of ani-
mals of all groups by Sigma-Aldrich insulin ELISA kit.Sampling
Oils treatment occurred within 4 weeks, after which the
rats were sacrificed, blood samples collected by cardiac
puncture and centrifuged within heparinized tubes at
3000 r.p.m for 20 min to obtain serum samples. Both
serum and liver were collected and stored at −80°C until
use. The removed hepatic tissues are homogenized in 9
volumes of ice-cold 10 mM Tris–HCl buffer, pH 7.4
containing Triton X-100 and 0.25 M sucrose using a
Brinkman homogenizer. The homogenate was centri-
fuged at 500 × g and 4°C for 20 min [30]. The obtained
supernatant was subjected to enzymes assay.
Enzyme assay
CAT activity was assayed as previously described [31].
One unit CAT is defined as that decomposes 1.0 μM of
H2O2/min at 25°C and pH 7. For arylsulfatases, one unit
of enzyme activity is defined as one nmol of p-nitrocate-
chol liberated per an hour under these assay conditions
[30]. The incubation mixture was incubated at 37°C and
the reaction, stopped after 30 min by adding 1 M NaOH
and measured for the absorbance at 515 nm.
Determination of kinetic parameters
The liver homogenate was collected from Control, GI,
GIII and GV and then subjected for purification for the
kinetic studies. ASA and ASB were purified as previously
described [30]. Time courses of the enzymes were per-
formed to determine the values of initial velocities at dif-
ferent substrate concentration ranges (2.0 – 10.0 mM and
10–50 mM for ASA and ASB, respectively) at the above
mentioned assay conditions. The values of Km and Vmax of
ASA and ASB were determined from Lineweaver-Burk
plots.
Protein assay
The protein is assayed as described previously [32] using
bovine serum albumin as a standard.
Statistical analyses
All the data are represented as mean ± S.E. The statis-
tical analysis was carried out using the student’s t-test
(SPSS version 16). All experiments were run on three
occasions for reproducibility, and all assays were done in
triplicate. Values were considered statistically significant
when p < 0.05.
Results
STZ injection induces diabetes leading to an increase in
BGL more than 120 mg/dl. BGLs were measured in the
different groups 3 days PI of STZ/oil treatment and
4 weeks PI of STZ/oil treatment (Figure 1), respectively.
All data were compared to the control group as a refe-
rence group. The control group showed a BGL range of
Figure 1 Blood glucose levels in the different groups 3 days and 4 weeks PI of STZ and oil treatment. Significant difference for all groups
is compared to the control represented by *p < 0.05, **p < 0.01, ***p < 0.001 and non-significant at p > 0.05.
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4.8 fold - increases, respectively with a significant increase
(p < 0.001) compared to the control. BGL in GII, GIV and
GVI groups showed a non-significant change (p > 0.05)
compared to the control. BGL in GIII, GV and GVII
groups showed a significant increase compared to the
control (p < 0.05). Insulin level was measured in the pan-
creatic tissues to assess the effect of the oil treatment on
damaged pancreatic tissues in STZ-treated rats. The dia-
betic group (GI) showed a significant decrease (4.0 fold) in
insulin compared to control (p < 0.001). Insulin level
showed a non-significant change in GII, GIV and GVI
groups (p > 0.05) and a significant increase in GIII, GV
and GVII groups (p < 0.05) compared to the control.
As shown in Figure 2, the specific activity of CAT in the
eight groups is illustrated for the liver tissue and serum,
respectively. The enzyme in control group showed specific
activities of (5.1 ± 0.04) × 10−3 and (1.652 ± 0.07) × 10−3
U/mg, respectively. The enzyme in GI showed a value of
(2.1 ± 0.06) × 10−3 and (0.31 ± 0.03) × 10−3 U/mg, re-
spectively with a significant decrease (p < 0.01) com-
pared to control. The enzyme in GII, GV and GVI
groups displayed a non-significant change (p > 0.05) com-
pared to control. In addition, the enzyme in GIII showed a
value of (4.6 ± 0.121) × 10−3 U/mg with a significant de-
crease (p = 0.023) and (1.037 ± 0.16) × 10−3 U/mg and with
a non-significant change (p = 0.119), respectively compared
to the control. The enzyme In GIV displayed a signifi-
cant decrease (p = 0.037) and a non-significant change
(p = 0.191), respectively compared to control. The
enzyme in GVII group displayed a significant decrease
(p < 0.05) compared to control.
The results in Figure 3a represent the hepatic ASA
and ASB specific activity in the eight groups after oil
treatment. The control group showed an ASA and ASB
specific activity of 85.25 ± 5.14 and 194 ± 11.57 U/mg for
ASA and ASB, respectively. ASA and ASB in GI groupshowed values of 1.5 (non-significant) and 1.6 fold-
increase (significant), respectively compared to control,
whereas the values in GII group were non-significantly
changed compared to the control. The enzymes in GIII,
GV and GVI groups showed a non-significant change of
compared to the control, whereas the values in GIV
group were non-significantly decreased compared to
control. The enzymes in GVII showed a significant in-
crease compared to control.
For serum ASA and ASB, the control group showed
an ASA and ASB specific activity of 4.5 ± 0.86 and
10.76 ± 1.975 U/mg, respectively. The enzymes in GI
and GVI groups displayed a non-significant change com-
pared to control. ASA and ASB in GII group displayed a
significant increase and a non-significant change, respect-
ively with respect to control. These enzymes in GIII group
displayed a non-significant change and a significant in-
crease, respectively compared to control. In GIV, GV and
GVII groups, the enzymes displayed a significant increase
and a non-significant change, respectively compared to
control (Figure 3b).
The initial velocity versus substrate concentrations for
ASA and ASB from the investigated group showed a
hyperbolic behavior and the initial rates of these en-
zymes increase on elevating the substrate concentrations
(Figure 4 a & b). The values of the kinetic constants
Vmax and Km of arylsulfatases increased after the induc-
tion of diabetes. These values are summarized in Table 1
for the hepatic enzymes from control and treated rats.
The purified ASA from the control group shows a Vmax
value of 22.8 ± 1.03 nmol/min/mg protein and a Km
value of 1.68 ± 0.011 mM. The enzyme from GI group
shows a significant increase of Vmax value and a signifi-
cant decrease of Km value compared to control. The en-
zyme from GIII and GV groups shows a non-significant
increase of Vmax and Km values compared to control.
The purified ASB from the control group shows a Vmax
Figure 2 Specific activity of hepatic and serum CAT (U/mg) 4 weeks PI of STZ and oil treatment. Significant difference for all groups is
compared to the control represented by *p < 0.05, **p < 0.01, ***p < 0.001 and non-significant at p > 0.05.
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value of 11.373 ± 0.089 mM. The enzyme from GI, GIII
and GV groups shows significance increase (p < 0.05) of
Vmax and Km values compared to control.
Discussion
A significant elevation in BGL in the diabetic rats com-
pared to control was reported [33]. The BGL in GV
group showed a decrease that is still non-significantly in-
creased compared to that of control group. This impliesFigure 3 Specific activities of hepatic (a) and serum (b) ASA & ASB in
difference for all groups is compared to the control represented by *p < 0.0that some oils were useful in improving BGL in DM.
Similar studies showed a significant decrease in BGL
after olive [21] and NS oils treatment [33] in diabetic
rats. The decrease in BGL in NS oil-treated diabetic rats
may be attributed to a decrease of gluconeogenesis in
liver [34,35]. It is well known that prolonged hyper-
glycemia favors the permanence of excessive hepatic
glucose output due to an increase of liver gluconeogene-
sis in DM caused by over expression of glucose-6-
phosphatase enzyme [36]. The canola oil treatment wasall groups 4 weeks PI of STZ and oil treatment. Significant
5, **p < 0.01, ***p < 0.001 and non-significant at p > 0.05.
Figure 4 Effect of different substrate concentrations on the initial velocities of hepatic ASA (a) and ASB (b) from the control, GI, GIII
and GV groups.
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GVII group occurs compared to the control group des-
pite its health benefits listed previously [37,38]. It was
found that canola oil-rich diets cause insulin resistance
thus favoring type 2 DM and omega-6 fatty acid whichTable 1 Kinetic parameters of ASA and ASB from control, GI,
control and GI groups
Enzymes Km
Control GI GIII GV
ASA 1.68 ± 0.01 1.48 ± 0.008 b 1.72 ± 0.015 y 1.768 ± 0.01
ASB 11.37 ± 0.089 8.5 ± 0.28 b 13.1 ± 0.208 b,z 12.37 ± 0.186
Superscript letters represented by a, b & c indicate a significant variation compared
and p < 0.001, respectively. No superscript letter is an indication for non-significant
in mM.is one of the important content of canola was confirmed
to mediate type 2 DM [39,40].
The results of the current study showed that hepatic
and serum CAT activity in oil-untreated diabetic rats de-
creases significantly compared to the control group.GIII and GV where the whole parameters are compared to
Vmax
Control GI GIII GV
y 22.8 ± 1.03 29.5 ± 0.29 a 25.66 ± 0.88 27.3 ± 1.06
a,z 33.33 ± 0.33 45.15 ± 0.15 c 39.66 ± 0.66 a,x 39.75 ± 0.75 a,x
to control group and x, y & z compared to diabetic group at p < 0.05, p < 0.01
variation at p > 0.05. Vmax is expressed in nmol/min/mg and Km is expressed
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creased significantly compared to the control group,
while that of GV showed a non-significant decrease
compared to the control group. CAT activity in sera for
each of GIII and GV was non-significantly decreased
compared to the control group but their activities were
greater than that of GI group. This is an evidence that
both oils improve the antioxidant defense mechanisms.
In an agreement of these results, it was found that NS
seed extract has antioxidant activity due to the flavo-
noids which quenchers O2
-. [41]. Also, NS seed extract-
treated diabetic rats showed a significant increase in the
hepatic and renal CAT activity [41]. Moreover, it was
confirmed that NS oil might play a role against the en-
zymatic alterations in the liver caused by Schistosoma
mansoni infection by improving the host immunity due
to the NS oil antioxidant activity [27]. However, it was
found that the olive oil hydrophilic fraction has an antioxi-
dant potential and a significant increase in the hepatic
CAT activity in rats subjected to herbicide treatment [42].
Another study also suggests that the olive oil phenolic
compounds have an antioxidant activity [26]. Therefore,
we suggest that the effect of NS and olive oils in the
current study may be attributed to their antioxidant ac-
tion. On the other hand, canola oil was not able to correct
the oxidative stress produced in DM. A reported study
that agrees to this finding reveals that the canola oil de-
creases the antioxidant status in hypertensive rats [43].
It was previously reported that STZ-induced diabetes
has an effect on the cellular glycosaminoglycan (GAG)
content and STZ-induced diabetes alters the synthesis
and catabolism of GAG [44]. Also, it was found that the
sulfation of heparan sulfate is reduced in the liver of
STZ-induced diabetic rats [45]. It was reported that sul-
fatides are required for normal insulin secretion [46] and
the promotion of proinsulin folding [47]. Moreover, it
was proven that sulfatides reduce the incidence of dia-
betes in non-obese diabetic mice compared to control
[48]. These findings support the data of ASA and ASB
in the present study. Accordingly, the elevation of both
hepatic ASA and ASB may be attributed to the alteration
of the modification of GAG sulfation and sulfatides con-
tent, respectively.
In fact, lysosomal membrane permeability occurs in
cell death process which also favors the amplification of
the death signaling. One of the essential factors that
contribute in the lysosomal membrane permeability is
ROS formation. In response to the increased ROS, in-
creased amounts of H2O2 can penetrate into lysosome.
The acidic environment of the lysosomal lumen en-
hances the reduction of iron and the generation of OH•
that stimulates the peroxidation of membrane lipids
leading to the outflow of lysosomal constituents into
cytosol [49]. Therefore, it could be suggested that theelevation in the hepatic ASA and ASB activities may be
related to lysosomal membrane permeabilization medi-
ated by oxidative stress, which is one of the predominat-
ing features in DM.
The determination of the Vmax and Km for each of
ASA and ASB allows the demonstration of the catalytic
alterations in these enzymes that occur under the patho-
logical circumstances. Since the kinetic behavior of both
ASA and ASB is hyperbolic in Figure 4, these enzymes
have the normal kinetic behavior and do not display the
allosteric characterization [50]. The Km values for ASA
and ASB from the diabetic group showed a significant
decrease in comparison to that of the control group sug-
gesting that there is a change in the substrate affinity for
the enzyme [50-52]. It was found previously that a slight
change in the ASA affinity results from Schistosomiasis
and this paralleled the non-significant change of the ac-
tivity [12]. Accordingly, the obtained data suggests that
the significant changes in the activity that occur in dia-
betes are related to the alterations in the catalytic site
and binding affinity for both ASA and ASB. It was previ-
ously reported that ASA and ASB are modified by sialy-
lation and phosphorylation in some tumors [53-55] and
ASB activity was changed due to its phosphorylated by
cAMP-dependent protein kinase in lung cancer [9,10].
Accordingly, we suggest a regulatory mechanism may be
involved in diabetes and may lead to a changed behavior
of arylsulfatases.Conclusion
The present work demonstrates that both NS and olive
oils are capable of improving the diabetic complications at
the enzymatic level. Their mechanistic action was sug-
gested to be attributed to an antioxidant activity. Con-
versely, canola oil showed an adverse effect in relation to
the diabetic complications and enzymatic alterations.
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